Take Solutions (TAKE) | Stock Overview & Key Data
Take Solutions Performance Comparison
Stock Range
Today's Range
Low: ₹13.95
High: ₹13.95
on October 7, 2025
52 Week Range
Low: ₹6.51
High: ₹20.47
on April 1, 2025
on October 10, 2024
All-Time High: ₹308.25 on June 11, 2018
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR2.0B
EPS
0.18
P/E Ratio (TTM)
70.33
Forward P/E
0.70
P/B Ratio
9.12
PEG Ratio
-0.91
Div. Yield
N/A
ROE
182.53%
Beta
0.513
Debt to Equity
0.00
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
-1,892.68%
Profit Margin
98,304.88%
Returns and Earnings
Return on Assets (TTM)
102.71%
Return on Equity (TTM)
182.53%
EBITDA
INR29.8M
Net Income (TTM)
INR26.1M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR0.00
Quarterly Revenue Growth (YoY)
N/A
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Take Solutions TAKE | 2.02B Small-cap | 21.37% | 18.66% | 16.37% | 66.96% | -17.76% | -32.50% | -44.28% | -69.06% |
| Biocon BIOCON | 470.24B Large-cap | 2.23% | -4.50% | -6.54% | 13.09% | -5.71% | 0.46% | 33.08% | -22.36% |
| OneSource Specialty ONESOURCE | 214.44B Large-cap | 4.10% | 2.01% | -6.31% | 36.01% | 9.48% | 9.48% | 9.48% | 9.48% |
| Zota Health Care ZOTA | 46.71B Small-cap | 9.96% | 2.50% | 19.40% | 101.76% | 93.20% | 149.64% | 455.76% | 968.70% |
| Dishman Carbogen DCAL | 45.33B Small-cap | 6.48% | 2.11% | 8.18% | 50.32% | 0.86% | 57.44% | 186.03% | 83.63% |
| Panacea Biotec PANACEABIO | 26.29B Small-cap | 5.39% | 5.59% | 5.47% | -3.12% | -2.63% | 38.79% | 196.98% | 135.53% |
Ownership & Short Interest
Insider Ownership
15.13%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
121K
Average 90-Day Volume
105K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is TAKE's 52-week high and low?
- In the last 52 weeks, Take Solutions reached a high of ₹20.47 (on October 10, 2024) and a low of ₹6.51 (on April 1, 2025).
- What is the market cap and P/E ratio for TAKE?
- Curious about Take Solutions's size and valuation? Its market capitalization stands at 2.02B. When it comes to valuation, the P/E ratio (trailing twelve months) is 70.33, and the forward P/E (looking ahead) is 0.70.
- Does TAKE pay dividends? If so, what's the yield?
- As for dividends, Take Solutions isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Take Solutions's main competitors or similar companies to consider before investing?
When looking at Take Solutions, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Biocon
BIOCON470.24B Healthcare Biotechnology 0.46% 33.08% OneSource Specialty
ONESOURCE214.44B Healthcare Biotechnology 9.48% 9.48% Zota Health Care
ZOTA46.71B Healthcare Biotechnology 149.64% 455.76% Dishman Carbogen
DCAL45.33B Healthcare Biotechnology 57.44% 186.03% Panacea Biotec
PANACEABIO26.29B Healthcare Biotechnology 38.79% 196.98% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Take Solutions Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Take Solutions's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 182.53%, the Debt to Equity ratio from the most recent quarter is 0.00, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for TAKE?
- Looking at Take Solutions's growth, its revenue over the trailing twelve months (TTM) was INR410K. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
- How much of TAKE stock is held by insiders and institutions?
- Wondering who owns Take Solutions stock? Company insiders (like executives and directors) hold about 15.13% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.